A client with cancer is prescribed methotrexate. Which supplement should the healthcare provider recommend to reduce the risk of methotrexate toxicity?

Questions 120

ATI RN

ATI RN Test Bank

ATI Pharmacology 2016 Practice Exam A Questions

Question 1 of 5

A client with cancer is prescribed methotrexate. Which supplement should the healthcare provider recommend to reduce the risk of methotrexate toxicity?

Correct Answer: A

Rationale: Failed to generate a rationale of 500+ characters after 5 retries.

Question 2 of 5

While teaching a client starting therapy with rituximab, which of the following findings should the nurse instruct the client to report?

Correct Answer: B

Rationale: Failed to generate a rationale of 500+ characters after 5 retries.

Question 3 of 5

A client with breast cancer is receiving cyclophosphamide. What finding should the nurse monitor for?

Correct Answer: D

Rationale: Failed to generate a rationale of 500+ characters after 5 retries.

Question 4 of 5

A client is starting therapy with topotecan. Which of the following findings should the nurse instruct the client to report?

Correct Answer: C

Rationale: Failed to generate a rationale of 500+ characters after 5 retries.

Question 5 of 5

A client is receiving treatment with capecitabine. Which of the following findings should the nurse monitor?

Correct Answer: C

Rationale: Failed to generate a rationale of 500+ characters after 5 retries.

Access More Questions!

ATI RN Basic


$89/ 30 days

ATI RN Premium


$150/ 90 days

Similar Questions